Clinical Trials Sponsored by Imbrium Therapeutics
Total 6211 results
-
Imbrium TherapeuticsPurdue Pharma LPRecruitingInterstitial Cystitis/Bladder Pain SyndromeUnited States
-
Imbrium TherapeuticsPurdue Pharma LPCompleted
-
Imbrium TherapeuticsPurdue Pharma LPActive, not recruiting
-
Imbria Pharmaceuticals, Inc.SuspendedRefractory AnginaUnited States
-
Imbria Pharmaceuticals, Inc.Active, not recruitingIschemia | Coronary Artery DiseaseDenmark, Finland, Sweden
-
Imbria Pharmaceuticals, Inc.Active, not recruitingNon-obstructive Hypertrophic CardiomyopathyUnited States, United Kingdom
-
Imbria Pharmaceuticals, Inc.University of OxfordRecruitingType 2 Diabetes | Diabetic Cardiomyopathies | HFpEF - Heart Failure With Preserved Ejection FractionUnited Kingdom
-
Ranok Therapeutics (Hangzhou) Co., Ltd.RecruitingAdvanced Solid Tumor | DLBCLUnited States
-
Akebia TherapeuticsCyclerion TherapeuticsCompletedType 2 Diabetes Mellitus With Diabetic NephropathyUnited States
-
Akebia TherapeuticsCyclerion TherapeuticsCompletedHeart Failure With Preserved Ejection FractionUnited States, Canada
-
CRISPR Therapeutics AGRecruitingClear Cell Renal Cell Carcinoma | Pancreatic Adenocarcinoma | Cervical Carcinoma | Malignant Pleural Mesothelioma | Esophageal CarcinomaUnited States
-
CRISPR Therapeutics AGActive, not recruitingT Cell LymphomaUnited States, Australia, Canada
-
CRISPR Therapeutics AGActive, not recruitingB-cell Lymphoma | Non-Hodgkin Lymphoma | B-cell Malignancy | Adult B Cell ALLUnited States, Spain, Canada, France, Germany, Australia
-
Bacainn Therapeutics, Inc.CompletedHealthy VolunteersUnited States
-
Celsus Therapeutics PLCTerminatedAtopic DermatitisIsrael
-
Eikon TherapeuticsImpact Therapeutics, Inc.RecruitingAdvanced Solid TumorUnited States
-
APRINOIA Therapeutics, LLCActive, not recruitingAlzheimer Disease | Tauopathies | Healthy VolunteersUnited States
-
CRISPR Therapeutics AGActive, not recruitingRenal Cell CarcinomaUnited States, Australia, Canada, Netherlands
-
CRISPR Therapeutics AGRecruitingFollicular Lymphoma | B-cell Lymphoma | Mantle Cell Lymphoma | Marginal Zone Lymphoma | Non-Hodgkin Lymphoma | B-cell Malignancy | Large B-cell Lymphoma | Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)United States
-
CRISPR Therapeutics AGEnrolling by invitationHematologic Malignancy | Solid MalignancyUnited States
-
CRISPR Therapeutics AGActive, not recruitingMultiple MyelomaUnited States, Spain, Australia, Canada
-
APRINOIA Therapeutics, LLCActive, not recruitingHealthy Volunteers | Alzheimer's Disease | Mild Cognitive Impairment Due to Alzheimer's DiseaseUnited States
-
CRISPR Therapeutics AGViaCyteRecruitingGlucose Metabolism Disorders | Immune System Diseases | Autoimmune Diseases | Diabetes Mellitus | Endocrine System Diseases | Diabetes Mellitus, Type 1 | Metabolic DiseaseCanada
-
iCell Gene TherapeuticsiCar Bio TherapeuticsNot yet recruitingHigh Risk Hematologic Malignancies | Relapsed and/or Refractory Acute Myeloid LeukemiaChina
-
Melinta Therapeutics, LLCRecruitingGram Positive Bacterial InfectionsUnited States
-
TenNor Therapeutics LimitedCompletedGram-Positive Bacterial Infections | Skin and Subcutaneous Tissue Bacterial InfectionsUnited States
-
CRISPR Therapeutics AGViaCyteCompletedGlucose Metabolism Disorders | Immune System Diseases | Autoimmune Diseases | Diabetes Mellitus | Endocrine System Diseases | Diabetes Mellitus, Type 1 | Metabolic DiseaseCanada
-
BlackThorn Therapeutics, Inc.Neumora Therapeutics, Inc.CompletedMajor Depressive DisorderUnited States
-
Sirion Therapeutics, Inc.ReVision Therapeutics, Inc.CompletedGeographic Atrophy | Dry Age Related Macular Degeneration
-
Ractigen Therapeutics.Not yet recruitingNon-Muscle-Invasive Bladder Cancer (NMIBC)
-
NeuShen TherapeuticsNot yet recruiting
-
Monopar TherapeuticsRecruitingGastric Cancer | Colorectal Cancer | Pancreatic Cancer | Ovarian Cancer | Lung Cancer | Bladder Cancer | Urothelial Carcinoma | Triple-negative Breast Cancer | Solid Tumor, AdultAustralia
-
vTv TherapeuticsNot yet recruitingDiabetes Mellitus, Type 1
-
Enliven TherapeuticsRecruitingColorectal Cancer | HER2-positive Breast Cancer | HER2-positive Gastric Cancer | HER2 Amplification | HER2 Positive Solid TumorsUnited States
-
OX2 TherapeuticsRecruitingDiffuse Midline Glioma, H3 K27M-Mutant | Recurrent High Grade GliomaUnited States
-
Transcend TherapeuticsNot yet recruitingA Single, Ascending Dose Evaluation of the Safety, Pharmacokinetics of Methylone in Healthy SubjectsPost Traumatic Stress DisorderAustralia
-
Remix TherapeuticsNot yet recruitingAcute Myeloid Leukemia | Myelodysplastic Syndromes | Acute Myeloid Leukemia Refractory | Higher Risk Myelodysplastic SyndromesUnited States
-
Encoded TherapeuticsNot yet recruiting
-
Dianthus TherapeuticsRecruitingMyasthenia Gravis, GeneralizedUnited States
-
Intellia TherapeuticsNot yet recruitingHereditary AngioedemaFrance, New Zealand, United Kingdom
-
Aprea TherapeuticsNot yet recruitingAdvanced Solid Tumor
-
ReCode TherapeuticsRecruitingCystic FibrosisNew Zealand
-
Repare TherapeuticsRecruiting
-
NovelMed TherapeuticsNot yet recruitingAnti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
-
Quanta TherapeuticsRecruiting
-
Transcend TherapeuticsNot yet recruitingPost Traumatic Stress DisorderAustralia
-
Atamyo TherapeuticsNot yet recruiting
-
Odyssey TherapeuticsRecruitingInflammatory Bowel Diseases | Crohn Disease | Ulcerative Colitis | Spondyloarthritis | Blau SyndromeAustralia
-
Orchard TherapeuticsRecruitingMPS-IH (Hurler Syndrome)Netherlands, United States, Italy, United Kingdom
-
Nektar TherapeuticsRecruitingModerate to Severe Atopic DermatitisUnited States, Canada